投融资数据库
免费查数据
注册送3天会员
首页>投融资
iCAD
收并购
iCAD Inc is a developer of artificial intelligence that empower radiologists to detect cancer. Products include the FDA approved, CE marked ProFound AI, a clinical decision support tool that provides an accurate two-year, breast cancer risk estimation that is personalized for each woman and is based only on a screening mammogram
基本信息
-
公司全称iCAD Inc
-
类型乳腺癌检测解决方案研发商
-
产业领域AI+辅助诊断、医疗信息化
-
公司人数51~100人
-
地址98 Spit Brook Rd Ste 100 NASHUA NEW HAMPSHIRE 03062-5737; US; Telephone: +16038825200; Fax: +16038803843;
-
联系电话+1 866-280-2239
-
邮箱support@icadmed.com
-
成立时间1984-01-01
投融资
-
2025-07-17
-
2025-07-17
-
2021-03-03
-
2020-04-28
-
2019-06-18
-
2019-06-18
-
2012-01-03
-
2012-01-03
-
1984-12-14
- 加载更多
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息